Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02990533 · ClinicalTrials.gov registry record · Phase 1
Muscle Anabolic Interventions to Accelerate Recovery From Hospitalization in Geriatric Patients
A Phase 1 study of Aging, sponsored by The University of Texas Medical Branch, Galveston.
- Completed
- Registry status
- Phase 1
- Development phase
- 80
- Enrollment target
- 1
- Study location
NCT02990533 is a Phase 1 study of Aging that has completed, run by The University of Texas Medical Branch, Galveston. The registered enrollment target is 80 participants, below the 2,194-participant average among 262 other Aging trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state.
The verdict
NCT02990533, a Phase 1 study of Aging, has completed, sponsored by The University of Texas Medical Branch, Galveston.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 80 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this pilot study is to collect preliminary data on the feasibility and effect size of interventions to modify the physiological recovery trajectory from hospitalization in community dwelling older adults.
Conditions Studied
Interventions
- DRUG Testosterone
- OTHER Placebo Injection
- DIETARY_SUPPLEMENT Protein Supplement
- OTHER Placebo supplement
Study Locations (1)
Texas
- Jennie Sealy Hospital - Galveston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2016-09 |
| Est. Completion | 2020-11-08 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02990533
The ClinicalTrials.gov registry entry for NCT02990533 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,194-participant average among 262 other Aging trials with a reported enrollment target (96% lower). The listed sponsor is The University of Texas Medical Branch, Galveston, which has 203 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Aging appearing as the primary indexed condition, and to 4 interventions - of which Testosterone is the first listed.
NCT02990533 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT02990533 about?
NCT02990533 is a clinical study titled "Muscle Anabolic Interventions to Accelerate Recovery From Hospitalization in Geriatric Patients". The goal of this pilot study is to collect preliminary data on the feasibility and effect size of interventions to modify the physiological recovery trajectory from hospitalization in community dwelling older adults.
What is the current status of trial NCT02990533?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 80 participants. The study started on 2016-09. Estimated completion is 2020-11-08.
What conditions does trial NCT02990533 study?
This clinical trial studies the following conditions: Aging.
What interventions are being tested in trial NCT02990533?
The interventions under investigation include: Testosterone (DRUG), Placebo Injection (OTHER), Protein Supplement (DIETARY_SUPPLEMENT), Placebo supplement (OTHER).
Who is sponsoring clinical trial NCT02990533?
This trial is sponsored by The University of Texas Medical Branch, Galveston, which has 203 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02990533 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Aging
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Effect of a Daily Supplement on Plasma PAI-1 Levels
RECRUITING · Phase 1
-
MTOR Inhibitors in Older Adults
RECRUITING · Phase 1
-
Rapalog Pharmacology (RAP PAC) Study
RECRUITING · Phase 1
-
Investigating the Persisting Effects of a Single Dose of Psilocybin on Structural Plasticity in Healthy Older Adults
RECRUITING · Phase 1
-
Fisetin to Improve Vascular Function in Older Adults
ACTIVE NOT RECRUITING · Phase 1
-
Wild Blueberries and Cardiovascular Health in Middle-aged/Older Men and Postmenopausal Women
ACTIVE NOT RECRUITING · Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.